Mirvetuximab soravtansine in folate receptor alpha (FRα)–high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

International Journal of Gynecological Cancer

Topics

Medicine

Cancer Oncology

Internal Medicine

Reproductive Medicine

Pathology And Forensic Medicine

Show all topics

DOI

10.1136/ijgc-2024-005401

License

CC-BY-NC

Other Formats

PDF